As of 2025-07-12, the Fair Value of Coherus BioSciences Inc (CHRS) is -5.65 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.88 USD, the upside of Coherus BioSciences Inc is -741.73%.
With the market price of 0.88 USD and our fair value calculation, Coherus BioSciences Inc (CHRS) is not a good investment. Investing in CHRS stocks now will result in a potential loss of 741.73%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 132.20 | -287.10 | -291.80 | -237.89 | 28.51 | -131.22 |
| YoY growth | 47.22% | -317.17% | -1.64% | 18.47% | 111.98% | -28.23% |
| Market Cap (mil) | 102.02 |
| P/E | |
| Forward P/E | 41.22x |
| EPS | -1.13 |
| Avg earnings growth rate | -28.23% |
| TTM earnings | -130.94 |